Periglaucine BCAS# 1025023-05-5 |
- Periglaucine A
Catalog No.:BCN5839
CAS No.:1025023-04-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1025023-05-5 | SDF | Download SDF |
PubChem ID | 24879470 | Appearance | Powder |
Formula | C20H23NO6 | M.Wt | 373.40 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CN1CCC23C14CC(C5=CC6=C(C=C52)OCO6)OC4(C(C(=O)C3)OC)OC | ||
Standard InChIKey | QJDYNQYLCIPODD-HVTWWXFQSA-N | ||
Standard InChI | InChI=1S/C20H23NO6/c1-21-5-4-18-8-13(22)17(23-2)20(24-3)19(18,21)9-16(27-20)11-6-14-15(7-12(11)18)26-10-25-14/h6-7,16-17H,4-5,8-10H2,1-3H3/t16-,17-,18-,19-,20-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Periglaucine B can inhibit hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. |
Targets | HBV |
Periglaucine B Dilution Calculator
Periglaucine B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6781 mL | 13.3905 mL | 26.7809 mL | 53.5619 mL | 66.9523 mL |
5 mM | 0.5356 mL | 2.6781 mL | 5.3562 mL | 10.7124 mL | 13.3905 mL |
10 mM | 0.2678 mL | 1.339 mL | 2.6781 mL | 5.3562 mL | 6.6952 mL |
50 mM | 0.0536 mL | 0.2678 mL | 0.5356 mL | 1.0712 mL | 1.339 mL |
100 mM | 0.0268 mL | 0.1339 mL | 0.2678 mL | 0.5356 mL | 0.6695 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Periglaucine A
Catalog No.:BCN5839
CAS No.:1025023-04-4
- GK921
Catalog No.:BCC8057
CAS No.:1025015-40-0
- Kushenol N
Catalog No.:BCN2984
CAS No.:102490-65-3
- RN 1747
Catalog No.:BCC7769
CAS No.:1024448-59-6
- Fmoc-Phg-OH
Catalog No.:BCC3312
CAS No.:102410-65-1
- Jasplakinolide
Catalog No.:BCC7485
CAS No.:102396-24-7
- AF-DX 116
Catalog No.:BCC6939
CAS No.:102394-31-0
- Glyburide
Catalog No.:BCC4784
CAS No.:10238-21-8
- Negsehisandrin G
Catalog No.:BCN2674
CAS No.:1023744-69-5
- Naringin
Catalog No.:BCN6312
CAS No.:10236-47-2
- Cadensin D
Catalog No.:BCN7260
CAS No.:102349-35-9
- (R)-Eriodictyol-8-C-beta-D-glucopyranoside
Catalog No.:BCN8028
CAS No.:1023271-51-3
- SGI-1776 free base
Catalog No.:BCC2232
CAS No.:1025065-69-3
- (-)-Huperzine A
Catalog No.:BCN1057
CAS No.:102518-79-6
- 2,3,23-Trihydroxy-12-oleanen-28-oic acid
Catalog No.:BCN1638
CAS No.:102519-34-6
- R788 disodium
Catalog No.:BCC3695
CAS No.:1025687-58-4
- Methyl lucidente G
Catalog No.:BCN8269
CAS No.:102607-20-5
- Ganoderic acid L
Catalog No.:BCN8204
CAS No.:102607-24-9
- Saprorthoquinone
Catalog No.:BCN3147
CAS No.:102607-41-0
- Pantoprazole
Catalog No.:BCC5432
CAS No.:102625-70-7
- SC-9
Catalog No.:BCC6646
CAS No.:102649-78-5
- SC-10
Catalog No.:BCC6643
CAS No.:102649-79-6
- RO-3
Catalog No.:BCC7548
CAS No.:1026582-88-6
- LB-100
Catalog No.:BCC5532
CAS No.:1026680-07-8
Periglaucines A-D, anti-HBV and -HIV-1 alkaloids from Pericampylus glaucus.[Pubmed:18396905]
J Nat Prod. 2008 May;71(5):760-3.
Four new hasubanane-type alkaloids, periglaucines A-D (1-4), and three known alkaloids, norruffscine (5), (-)-8-oxotetrahydropalmatine (6), and (-)-8-oxocanadine (7), were isolated from the aerial parts of Pericampylus glaucus. Their structures were elucidated on the basis of extensive NMR and EIMS data, and that of periglaucine A (1) was confirmed by single-crystal X-ray diffraction. Alkaloids 1-4 inhibited hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. (-)-8-Oxotetrahydropalmatine (6) possessed a high selectivity index (SI = 22.4) for HBsAg secretion of the Hep G2.2.15 cell line with an IC(50) value of 0.14 mM. Norruffscine (5) and (-)-8-oxotetrahydropalmatine (6) exhibited inhibitory activity against human immunodeficiency virus (HIV-1) with EC(50) values of 10.9 and 14.1 microM in C8166 cells (SI = 45.7 and 18.8), respectively.